Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?Francesca Daniel, Antonio Frassoldati, Lorenzo Belluomini et al.|Annals of Oncology|2016Cited by 1
Estrogen receptor mutation: a new strategy to overcome endocrine resistanceAndrea Moretti, Antonio Frassoldati, Luca Martella et al.|Annals of Oncology|2017Cited by 1